Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Change in Acquisitions & Divestments came in at $4.0 million in Q2 2026, up 300.0% year-over-year from $1.0 million in Q2 2025, and up 300.0% quarter-over-quarter from $1.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Change in Acquisitions & Divestments (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Change in Acquisitions & Divestments across 18 years of filings, most recently posting $4.0 million for Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments rose 300.0% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $8.0 million (down 33.33% YoY), while the FY2025 annual figure was $8.0 million, down 42.86% from the prior year.
  • Change in Acquisitions & Divestments came in at $4.0 million for Q2 2026 at Bausch Health Companies, up from $1.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $13.0 million in Q4 2023 to a low of -$2.0 million in Q2 2023.
  • Average Change in Acquisitions & Divestments over 5 years is $4.2 million, with a median of $4.0 million recorded in 2023.
  • The largest YoY upside for Change in Acquisitions & Divestments was 550.0% in 2023 against a maximum downside of 128.57% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $2.0 million in 2022, then soared by 550.0% to $13.0 million in 2023, then plunged by 76.92% to $3.0 million in 2024, then slumped by 33.33% to $2.0 million in 2025, then soared by 100.0% to $4.0 million in 2026.
  • Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $4.0 million in Q2 2026, $1.0 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.00 Mn
Mar 31, 2026 1.00 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2025 4.00 Mn
Dec 31, 2024 3.00 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 1.00 Mn
Mar 31, 2024 6.00 Mn
Dec 31, 2023 13.00 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 11.00 Mn
Dec 31, 2022 2.00 Mn
Sep 30, 2022 7.00 Mn
Jun 30, 2022 7.00 Mn
Mar 31, 2022 6.00 Mn
Dec 31, 2021 4.00 Mn
Sep 30, 2021 3.00 Mn